Carlo Pomari

463 total citations
34 papers, 343 citations indexed

About

Carlo Pomari is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Carlo Pomari has authored 34 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 16 papers in Physiology and 5 papers in Surgery. Recurrent topics in Carlo Pomari's work include Asthma and respiratory diseases (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Respiratory and Cough-Related Research (10 papers). Carlo Pomari is often cited by papers focused on Asthma and respiratory diseases (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers) and Respiratory and Cough-Related Research (10 papers). Carlo Pomari collaborates with scholars based in Italy and United States. Carlo Pomari's co-authors include Silvia Tognella, Claudio Micheletto, Paola Turco, Roberto Walter Dal Negro, Roberto W. Dal Negro, Gianenrico Senna, Marco Caminati, Massimo Guerriero, Giuseppe Zamboni and Alberto Terzi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Emerging infectious diseases and Clinical Pharmacokinetics.

In The Last Decade

Carlo Pomari

33 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlo Pomari Italy 10 190 129 85 36 28 34 343
C. I. Backhouse Chile 11 69 0.4× 79 0.6× 100 1.2× 86 2.4× 37 1.3× 30 374
C. A. Henderson United Kingdom 7 115 0.6× 81 0.6× 14 0.2× 118 3.3× 13 0.5× 9 400
Alejandro Raimondi Argentina 9 233 1.2× 105 0.8× 14 0.2× 34 0.9× 7 0.3× 23 419
Adrien Bigot France 7 116 0.6× 146 1.1× 22 0.3× 75 2.1× 6 0.2× 34 351
Munehiko Morishita Japan 12 177 0.9× 234 1.8× 51 0.6× 33 0.9× 50 1.8× 22 430
Fumiaki Kiyomi Japan 11 181 1.0× 56 0.4× 104 1.2× 58 1.6× 7 0.3× 36 365
Scott Morris United Kingdom 6 73 0.4× 100 0.8× 18 0.2× 37 1.0× 20 0.7× 7 390
Henk K. van Halteren Netherlands 11 50 0.3× 93 0.7× 167 2.0× 62 1.7× 22 0.8× 28 336
Venkateshwar Polsani United States 11 112 0.6× 56 0.4× 18 0.2× 180 5.0× 11 0.4× 47 530
V. L. Emanuel Russia 7 34 0.2× 94 0.7× 19 0.2× 30 0.8× 8 0.3× 87 277

Countries citing papers authored by Carlo Pomari

Since Specialization
Citations

This map shows the geographic impact of Carlo Pomari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Pomari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Pomari more than expected).

Fields of papers citing papers by Carlo Pomari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Pomari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Pomari. The network helps show where Carlo Pomari may publish in the future.

Co-authorship network of co-authors of Carlo Pomari

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Pomari. A scholar is included among the top collaborators of Carlo Pomari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Pomari. Carlo Pomari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inno, Alessandro, Giuseppe Bogina, Matteo Salgarello, et al.. (2023). First-line tepotinib for a very elderly patient with metastatic NSCLC harboring MET exon 14 skipping mutation and high PD-L1 expression. SHILAP Revista de lepidopterología. 17. 110–113. 3 indexed citations
2.
Guerriero, Massimo, Zeno Bisoffi, Albino Poli, Claudio Micheletto, & Carlo Pomari. (2020). Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a cross-sectional study protocol. BMJ Open. 10(10). e040036–e040036. 3 indexed citations
3.
Bertoglio, Pietro, Andrea Viti, S. Paiano, et al.. (2018). IgG4-related disease: a new challenging diagnosis mimicking lung cancer. Interactive Cardiovascular and Thoracic Surgery. 28(3). 410–412. 8 indexed citations
4.
Munari, Enrico, Giuseppe Zamboni, Marcella Marconi, et al.. (2017). PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability. Oncotarget. 8(52). 90123–90131. 81 indexed citations
5.
Bertolaccini, Luca, et al.. (2016). Indwelling Pleural Catheters. Thoracic surgery clinics/Thorac. surg. clin.. 27(1). 47–55. 2 indexed citations
6.
Pomari, Carlo, S. Paiano, Luca Bertolaccini, et al.. (2016). Bronchial reacutization and gastroesophageal reflux: is there a potential clinical correlation?. Annals of Translational Medicine. 4(16). 304–304. 7 indexed citations
7.
Guerriero, Massimo, Marco Caminati, Giovanni Viegi, et al.. (2015). COPD prevalence in a north-eastern Italian general population. Respiratory Medicine. 109(8). 1040–1047. 20 indexed citations
8.
Caminati, Marco, Gianenrico Senna, Fulvia Chieco Bianchi, et al.. (2014). Omalizumab management beyond clinical trials: The added value of a network model. Pulmonary Pharmacology & Therapeutics. 29(1). 74–79. 17 indexed citations
9.
10.
Negro, Roberto Walter Dal, Carlo Pomari, Silvia Tognella, & Claudio Micheletto. (2003). Salmeterol & Fluticasone 50 μg/250 μg bid in combination provides a better long-term control than salmeterol 50 μg bid alone and placebo in COPD patients already treated with theophylline. Pulmonary Pharmacology & Therapeutics. 16(4). 241–246. 48 indexed citations
11.
Pomari, Carlo, et al.. (1999). Prevalence of gastro-oesophageal reflux in asthmatics: an Italian study.. PubMed. 31(5). 371–5. 9 indexed citations
12.
Pomari, Carlo, et al.. (1993). Famotidine and Theophylline Pharmacokinetics. Clinical Pharmacokinetics. 24(3). 255–258. 10 indexed citations
13.
14.
Negro, Roberto Dal, et al.. (1991). Calcitonin nasal spray in patients with chronic asthma: a double-blind crossover study vs placebo.. PubMed. 29(4). 144–6. 10 indexed citations
15.
Pomari, Carlo, et al.. (1989). Has Theophylline a Role in the Cure and Prevention of ACE-Inhibitor-Related Cough?. Respiration. 55(2). 119–121. 3 indexed citations
16.
Turco, Paola, et al.. (1988). Miocamycin doesn't affect theophylline serum levels in COPD patients.. PubMed. 26(1). 27–9. 6 indexed citations
17.
Turco, Paola, et al.. (1987). Clinical Use of Controlled-Release Theophylline in Chronic Airways Obstruction. Journal of International Medical Research. 15(6). 391–396. 2 indexed citations
18.
Turco, Paola, et al.. (1987). Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation.. PubMed. 25(7). 401–5. 4 indexed citations
19.
Pomari, Carlo, et al.. (1986). Protection against non-specific bronchial hyperreactivity and bronchodilating action of procaterol in atopics.. PubMed. 24(6). 323–5. 1 indexed citations
20.
Pomari, Carlo, et al.. (1984). Multiparametrical approach to fog-challenge-induced bronchial hyperreactivity in asthmatics--protective effects of salbutamol plus beclomethasone dipropionate.. PubMed. 22(9). 515–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. I. Backhouse Breakdown of academic impact, for papers by C. A. Henderson Breakdown of academic impact, for papers by Alejandro Raimondi Breakdown of academic impact, for papers by Adrien Bigot Breakdown of academic impact, for papers by Munehiko Morishita Breakdown of academic impact, for papers by Fumiaki Kiyomi Breakdown of academic impact, for papers by Scott Morris Breakdown of academic impact, for papers by Henk K. van Halteren Breakdown of academic impact, for papers by Venkateshwar Polsani Breakdown of academic impact, for papers by V. L. Emanuel
Rankless by CCL
2026